Navigation Links
Artemis Health Hires Richard Rava, Ph.D., as Senior Vice President of Research and Development
Date:2/9/2009

MENLO PARK, Calif., Feb. 9 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that Richard Rava, Ph.D., has joined Artemis Health in the newly created position of senior vice president of research and development.

"Rich's depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him uniquely suited to lead our efforts to bring non-invasive prenatal diagnostic tests to the market," said Lissa Goldenstein, president and chief executive officer of Artemis Health.

Dr. Rava brings more than 20 years of research, development and operational expertise in molecular and genetic analysis for commercial assays and instrumentation. He comes to Artemis after 16 years at Affymetrix where he was a scientific co-founder and most recently senior vice president of research and development. During his tenure, Dr. Rava led the research, development and manufacturing scale-up of the Affymetrix' GeneChip(R) technology. He was responsible for the delivery of multiple products involving complex assays, microarrays, instrumentation and software that applied scientific technology to meet the needs of the gene expression, genetics research and clinical markets.

Prior to co-founding Affymetrix, Dr. Rava served as a senior scientist at Affymax Research Institute. From 1990 through 1992, he served as principal research scientist at the George R. Harrison Spectroscopy Laboratory, Massachusetts Institute of Technology (MIT). During that time, he was also the research coordinator for the National Institute of Health Laser Biomedical Research Center at MIT. Dr. Rava has published over 60 papers in peer-reviewed scientific publications and is an author on over 30 issued U.S. patents. He received
'/>"/>

SOURCE Artemis Health Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Exelixis Sells 80% Stake in Artemis to Taconic
2. Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
10. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Researchers from the National Institute of Standards and Technology (NIST) and the Naval Research Laboratory have developed a new way to introduce magnetic impurities in a semiconductor crystal by pro
(Date:12/4/2009)CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmer
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/4/2009)NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chroni
Breaking Biology Technology:NIST researchers put a new spin on atomic musical chairs 2Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Alberta companies delivering new products to the health & medical marketplace 2Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2
... Bionovo, Inc.,(Nasdaq: BNVI ), a leader in the ...ugs in the areas of women,s health and cancer, tod...ionovo, Inc., will present at the 4th,Annual BIO I...n October 11, 2007 at 12:30 p.m. PDT,at the Palace...t and slide presentation of the event will be,avai...
... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE:...ve agreement under which it has acquired Haptogen,... focused on the discovery,of biopharmaceutical the...yeth,s already robust biotechnology drug discovery...of next-generation biotechnology,discovery technol...
... 4 Lexicon,Pharmaceuticals, Inc. (Nasdaq: LXRX )... Lexicon,s president and chief executive officer, ...e Hotel in San Francisco, California,on Thursday, ...ve webcast of Lexicon,s presentation may be access...ma.com . An archived version of the,webcast will b...
Other Biology Technology:Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery 2Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery 3Lexicon Pharmaceuticals to Present at Bio InvestorForum 2
(Date:12/4/2009)The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest
(Date:12/4/2009)UVALDE Dr. Daniel Leskovar, a Texas AgriLife Research plant physiologist at the Texas AgriLife Research and Extension Center in Uvalde, has been investigating ways to help vegetable plants make a les
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
Breaking Biology News(10 mins):Stem cells battle for space 2Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Lower income women report more insurance-based discrimination during pregnancy, delivery 2Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 1Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 2Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 3Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 4Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 5Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 6Cantel Medical Reports 65 25 Increase In Net Income EPS of 240 26 vs 240 16 For Quarter Ended July 31 2009 59196 7Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 1Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 2Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 3Soligenix Appoints Robert J Rubin MD to its Board of Directors 14405 4Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 5361 1Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results 5361 2
... as REST blocks the expression of a microRNA that ...mselves and causes them to differentiate into spec...exas M. D. Anderson Cancer Center report in the jo...ranscription factor (REST) plays a dual role in em...mder, Ph.D., professor in M. D. Andersons Departme...
...ss. -- New technology at Tufts University,s Center...ers to translate the most abstract, complex scient...onal images than conventional visualization system...the National Science Foundation, Tufts, new 14-foo...tion of advanced features found nowhere else in Ne...
...e world in a way that had never been observed in a...20th Current Biology, a Cell Press publication. Th...ystemsuggests that the ability to perceive circula...mode of communication. , Mantis shrimp ventured i...l of the University of Queensland in Australia. Al...
Other Biology News:Protein protects embryonic stem cells' versatility and self-renewal 2Protein protects embryonic stem cells' versatility and self-renewal 3Visual technology enables brain to learn in new ways 2Visual technology enables brain to learn in new ways 3Visual technology enables brain to learn in new ways 4Mantis shrimp vision reveals new way that animals can see 2Mantis shrimp vision reveals new way that animals can see 3
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Rabbit Anti-ISOCITRATE DEHYDROGENASE Polyclonal Antibody, Unconjugated from AbD Serotec
... two highly efficient methods of identifying recom...consuming plasmid preparation. By using the large-...s to transfer partial colonies of E. coli bacteria...solutions provided by the kits and immediately run...
Biology Products: